Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0043 | 0.0093 | 0.0234 |
Echinococcus granulosus | protein kinase shaggy | 0.0117 | 0.1026 | 0.1026 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0517 | 0.0517 |
Schistosoma mansoni | jumonji domain containing protein | 0.0092 | 0.0707 | 0.0707 |
Loa Loa (eye worm) | protein kinase domain-containing protein | 0.028 | 0.307 | 0.7752 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0117 | 0.1026 | 0.259 |
Echinococcus multilocularis | casein kinase I delta | 0.0351 | 0.396 | 0.396 |
Brugia malayi | RNA binding protein | 0.0076 | 0.0517 | 0.1306 |
Echinococcus multilocularis | casein kinase i | 0.0351 | 0.396 | 0.396 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0117 | 0.1026 | 0.259 |
Echinococcus granulosus | casein kinase i | 0.0351 | 0.396 | 0.396 |
Brugia malayi | casein kinase 1, delta | 0.0351 | 0.396 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0093 | 0.0093 |
Echinococcus multilocularis | protein kinase shaggy | 0.0117 | 0.1026 | 0.1026 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0351 | 0.396 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0313 | 0.0791 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0351 | 0.396 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0093 | 0.0093 |
Brugia malayi | casein kinase I | 0.0351 | 0.396 | 1 |
Onchocerca volvulus | 0.0117 | 0.1026 | 0.259 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0517 | 0.0517 |
Echinococcus granulosus | casein kinase I delta | 0.0351 | 0.396 | 0.396 |
Brugia malayi | Protein kinase domain containing protein | 0.028 | 0.307 | 0.7752 |
Echinococcus granulosus | casein kinase I alpha | 0.0351 | 0.396 | 0.396 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0315 | 0.0796 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0351 | 0.396 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0351 | 0.396 | 1 |
Onchocerca volvulus | 0.0345 | 0.3876 | 0.9788 | |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0075 | 0.0188 |
Loa Loa (eye worm) | casein kinase | 0.0274 | 0.2986 | 0.754 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0117 | 0.1026 | 0.259 |
Plasmodium vivax | casein kinase 1, putative | 0.0351 | 0.396 | 1 |
Toxoplasma gondii | casein kinase I | 0.0351 | 0.396 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.0517 | 0.1306 |
Echinococcus multilocularis | casein kinase I gamma | 0.028 | 0.307 | 0.307 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0313 | 0.0791 |
Giardia lamblia | Kinase, CMGC GSK | 0.0117 | 0.1026 | 0.259 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.047 | 0.1186 |
Echinococcus multilocularis | casein kinase I alpha | 0.0351 | 0.396 | 0.396 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.0517 | 0.0517 |
Giardia lamblia | Kinase, CK1 Casein kinase | 0.0351 | 0.396 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0517 | 0.0517 |
Echinococcus multilocularis | casein kinase I alpha | 0.0351 | 0.396 | 0.396 |
Brugia malayi | intracellular kinase | 0.0117 | 0.1026 | 0.259 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0115 | 0.1004 | 0.1004 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0117 | 0.1026 | 0.1026 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.0517 | 0.0517 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0517 | 0.0517 |
Trypanosoma cruzi | casein kinase, putative | 0.0351 | 0.396 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0351 | 0.396 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0313 | 0.0791 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0117 | 0.1026 | 0.1026 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0043 | 0.0093 | 0.0093 |
Trypanosoma cruzi | casein kinase, putative | 0.0351 | 0.396 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.0517 | 0.1306 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0115 | 0.1004 | 0.1004 |
Echinococcus granulosus | casein kinase I alpha | 0.0351 | 0.396 | 0.396 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0351 | 0.396 | 1 |
Entamoeba histolytica | casein kinase, putative | 0.0351 | 0.396 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0345 | 0.3876 | 0.9714 |
Trypanosoma cruzi | casein kinase, putative | 0.0351 | 0.396 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.028 | 0.307 | 0.307 |
Entamoeba histolytica | casein kinase 1, putative | 0.0351 | 0.396 | 1 |
Echinococcus multilocularis | casein kinase I delta | 0.0351 | 0.396 | 0.396 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0117 | 0.1026 | 0.259 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.0517 | 0.1306 |
Echinococcus granulosus | jumonji domain containing protein | 0.0049 | 0.0173 | 0.0173 |
Schistosoma mansoni | protein kinase | 0.0351 | 0.396 | 0.396 |
Trypanosoma cruzi | casein kinase, putative | 0.0351 | 0.396 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0075 | 0.0188 |
Leishmania major | casein kinase, putative | 0.0351 | 0.396 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0117 | 0.1026 | 0.259 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0075 | 0.0075 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.0517 | 0.1306 |
Echinococcus granulosus | casein kinase I delta | 0.0351 | 0.396 | 0.396 |
Brugia malayi | jmjC domain containing protein | 0.0043 | 0.0093 | 0.0234 |
Plasmodium falciparum | casein kinase 1 | 0.0351 | 0.396 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0351 | 0.396 | 0.396 |
Loa Loa (eye worm) | CK1/CK1/CK1-D protein kinase | 0.0351 | 0.396 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0117 | 0.1026 | 0.1026 |
Echinococcus granulosus | casein kinase I gamma | 0.028 | 0.307 | 0.307 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0351 | 0.396 | 0.396 |
Echinococcus multilocularis | casein kinase I alpha | 0.0351 | 0.396 | 0.396 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0043 | 0.0093 | 0.0093 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.0517 | 0.1306 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0313 | 0.0791 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0049 | 0.0173 | 0.0173 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0517 | 0.0517 |
Onchocerca volvulus | 0.0351 | 0.396 | 1 | |
Trypanosoma cruzi | casein kinase, putative | 0.0351 | 0.396 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0115 | 0.1004 | 0.2534 |
Giardia lamblia | Kinase, CMGC GSK | 0.0117 | 0.1026 | 0.259 |
Trypanosoma brucei | casein kinase I, isoform 2 | 0.0351 | 0.396 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.7783 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.5733 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (binding) | = 7.0795 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (binding) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (binding) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Saccharomyces cerevisiae | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.